Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how
Close

Takeda Pharmaceutical Co Ltd ADR (TAK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Takeda Pharma ADR's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.24 -0.12    -0.93%
10/05 - Closed. Currency in USD ( Disclaimer )
After Hours
13.25
0.01
0.06%
16:12:35 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,860,421
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 13.17 - 13.30
Takeda Pharma ADR 13.24 -0.12 -0.93%

TAK Balance Sheet

 
Featured here, the Balance Sheet for Takeda Pharmaceutical Co Ltd ADR, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 2558580 2428830 2462066 2472017
Cash and Short Term Investments 457800 288359 318051 316380
Cash - - - -
Cash & Equivalents 457800 288359 318051 316380
Short Term Investments - - - -
Total Receivables, Net 697610 743079 788066 825481
Accounts Receivables - Trade, Net 668403 716230 755327 792895
Total Inventory 1209869 1169640 1155866 1083374
Prepaid Expenses - - - -
Other Current Assets, Total 193301 227752 200083 246782
Total Assets 15108792 14222947 14871889 14792738
Property/Plant/Equipment, Total - Net 1989777 1841499 1894136 1795315
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 5410067 5111287 5301017 5182128
Intangibles, Net 4274682 4097022 4402421 4514084
Long Term Investments 89831 103312 103112 100421
Note Receivable - Long Term 29207 26849 32739 32586
Other Long Term Assets, Total 391990 324308 372926 353251
Other Assets, Total 1099425 971002 904094 880197
Total Current Liabilities 2313103 2282168 2367617 2501741
Accounts Payable 547521 483666 421078 440924
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 367251 370292 274841 416860
Other Current liabilities, Total 1398331 1428210 1671698 1643957
Total Liabilities 7834787 7480340 7800864 7871069
Total Long Term Debt 5164334 4835998 4979237 4825748
Long Term Debt 4476501 4293872 4404363 4330254
Capital Lease Obligations 687833 542126 574874 495494
Deferred Income Tax 113777 133036 228719 269549
Minority Interest 741 673 673 617
Other Liabilities, Total 242832 -508035 -522782 -467386
Total Equity 7274005 6742607 7071025 6921669
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 1676596 1676543 1676503 1676411
Additional Paid-In Capital 1747414 1730138 1711109 1741937
Retained Earnings (Accumulated Deficit) 1391203 1396838 1446018 1490097
Treasury Stock - Common -51259 -51253 -51246 -100255
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 2510051 1990341 2288641 2113479
Total Liabilities & Shareholders' Equity 15108792 14222947 14871889 14792738
Total Common Shares Outstanding 1569.01 1568.91 1568.89 1554.57
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TAK Comments

Write your thoughts about Takeda Pharmaceutical Co Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Feng Guo An
Feng Guo An Jan 28, 2022 8:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy now at $14.4 and wait for 1~2 month return to $16
Victor Rosenberg
Victor Rosenberg Jul 12, 2021 6:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Which is P/E Ratio of TAK?
Victor Rosenberg
Victor Rosenberg Jul 12, 2021 6:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
PE Ratio (TTM) 15.44 from another source
Victor Rosenberg
Victor Rosenberg Jul 12, 2021 6:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's going on? I thought this share wll be 12 $
Edwin Henriquez
Edwin Henriquez Jun 16, 2021 3:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happened to the FDA decision 🤔
Brian Yi
Brian Yi Jun 14, 2021 2:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA decision tommorrow
Jay Clays
Jay Clays Jan 21, 2021 3:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dividend yield shows as 1.22 (8.16%), I believe this is incorrect information as both NasdaqCom and Finviz + Yahoo Finance show a Yield of  4.13% and 4.84% respectively  - I don't understand why so much incongruence between sources, is anyone able to explain? Thanks!
Mihalis Panczyk
Mihalis Panczyk Jan 21, 2021 3:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
could be related to the way it is calculated (taking into account the last available price vs average of last 12months)
shahid ismail
BoldBoss Jan 12, 2021 5:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARK bought 1.2 Million yesterday
manchie manchie
manchie Jan 08, 2021 10:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is going up..volume doubled in the last two days
Jean Mercredi
Jean Mercredi Dec 17, 2020 11:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's going on guys?
ab al
ab al Dec 13, 2020 3:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's going to 21$ soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email